Compounded Semaglutide & Tirzepatide: The Definitive Patient Safety Guide
Everything you need to know about the science, legality, 503A/503B compounding standards, and how to verify that your medication is safe and authentic.
Compounded semaglutide and tirzepatide are prepared by licensed 503A or 503B pharmacies during FDA-recognized shortages. Compounded drugs are not reviewed or approved by the FDA for safety and effectiveness. While compounded medications are prepared by state-licensed pharmacies from pure Active Pharmaceutical Ingredients (APIs), the final compounded product does not undergo individual FDA pre-market approval.
What Exactly is Compounded GLP-1?
Drug compounding is the legal practice in which a licensed pharmacist combines, mixes, or alters ingredients to create a tailored medication for an individual patient upon receipt of a valid prescription.
Due to severe nationwide shortages of branded GLP-1 receptor agonists—such as Novo Nordisk’s Wegovy® / Ozempic® (semaglutide) and Eli Lilly’s Zepbound® / Mounjaro® (tirzepatide)—licensed compounding pharmacies are legally permitted under federal law to compound customized versions using pharmaceutical-grade active ingredients to ensure patient continuity of care.
503A vs 503B Pharmacies: Understanding the Difference
Not all compounding facilities operate under identical legal frameworks. The US Drug Quality and Security Act (DQSA) created two distinct categories:
State-Licensed Traditional Pharmacies
- ✓Requires a patient-specific prescription before compounding
- ✓Regulated directly by State Boards of Pharmacy (USP 797 standards)
- ✓Examples: Hallandale Pharmacy, Red Rock, Empower, Boothwyn
- ✓Represents over 85% of online GLP-1 telehealth shipments
FDA-Registered Outsourcing Facilities
- ✓Can compound batches without patient-specific prescriptions upfront
- ✓Subject to strict FDA inspections and Current Good Manufacturing Practice (cGMP)
- ✓Examples: BPI Labs, Fagron, QuVa Pharma
- ✓Subject to higher manufacturing standards comparable to commercial pharma
FDA Warning: Semaglutide Sodium & Acetate Salts
The FDA has issued explicit alerts warning consumers about pharmacies and unverified websites using salt forms of semaglutide (such as semaglutide sodium or semaglutide acetate).
Salt forms have different molecular structures than the FDA-approved base molecule and have not been proven safe or effective in clinical trials. Every provider tracked in GLP-1 Guard's registry is screened to verify that only compliant semaglutide base is utilized.
Why Do Pharmacies Add Vitamin B12 or B6?
Many compounding pharmacies formulate semaglutide with cyanocobalamin (Vitamin B12), pyridoxine (Vitamin B6), or glycine. There are two primary reasons for this practice:
4 Steps to Verify Any Online Provider's Pharmacy
The telehealth service should explicitly name the partner dispensing facility. If they refuse to disclose it, cancel your order immediately.
Verify that the pharmacy holds an active non-resident sterile compounding license in your home state via your state's Department of Health registry.
Reputable compounders perform third-party potency, sterility, and endotoxin batch testing. Patient support can supply the lot COA on request.
The label must state the active ingredient concentration (e.g., 2.5mg/mL), beyond-use date (BUD), lot number, patient name, and prescribing clinician's credentials.
Ready to Compare Audited Providers?
See our updated 2026 registry comparing all legitimate 503A and 503B compound GLP-1 telehealth providers side by side.